Annex

United Kingdom

The entry Sodium salicylate in Table 1 of the Annex to Regulation (EU) No 37/2010 shall be replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Sodium salicylate NOT APPLICABLE Bovine, porcine No MRL required NOT APPLICABLE
For oral use.

Not for use in animals from which milk is produced for human consumption.
NO ENTRY
All food producing species except fin fish No MRL required NOT APPLICABLE For topical use only.
Salicylic acid Turkey 400 μg/kg Muscle
Not for use in animals producing eggs for human consumption.

Provisional maximum residue limits shall expire on 1 January 2015.
Anti-inflammatory agents/Non-steroidal anti-inflammatory agents’
2 500 μg/kg Skin and fat
200 μg/kg Liver
150 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Sodium salicylate	NOT APPLICABLE	Bovine, porcine	No MRL required	NOT APPLICABLE	For oral use. Not for use in animals from which milk is produced for human consumption.	NO ENTRY
	NOT APPLICABLE	All food producing species except fin fish	No MRL required	NOT APPLICABLE	For topical use only.	NO ENTRY
	Salicylic acid	Turkey	400 μg/kg	Muscle	Not for use in animals producing eggs for human consumption. Provisional maximum residue limits shall expire on 1 January 2015.	Anti-inflammatory agents/Non-steroidal anti-inflammatory agents’
			2 500 μg/kg	Skin and fat
			200 μg/kg	Liver
			150 μg/kg	Kidney